PortfoliosLab logoPortfoliosLab logo
ATAI vs. DCTH
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

ATAI vs. DCTH - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Atai Life Sciences N.V. (ATAI) and Delcath Systems, Inc. (DCTH). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, ATAI achieves a 10.02% return, which is significantly higher than DCTH's 6.83% return.


ATAI

1D
-0.66%
1M
12.50%
YTD
10.02%
6M
2.27%
1Y
82.19%
3Y*
35.22%
5Y*
10Y*

DCTH

1D
4.45%
1M
-6.42%
YTD
6.83%
6M
7.68%
1Y
-34.13%
3Y*
17.10%
5Y*
0.06%
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

ATAI vs. DCTH - Yearly Performance Comparison


2026 (YTD)20252024202320222021
ATAI
Atai Life Sciences N.V.
10.02%207.52%-5.67%-46.99%-65.14%-60.77%
DCTH
Delcath Systems, Inc.
6.83%-16.11%189.42%15.56%-53.55%-23.95%

Correlation

The correlation between ATAI and DCTH is 0.30, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.30

Correlation (3Y)
Calculated over the trailing 3-year period

0.27

Correlation (All Time)
Calculated using the full available price history since Jun 21, 2021

0.22

Fundamentals

Market Cap

ATAI:

$1.61B

DCTH:

$388.67M

EPS

ATAI:

-$2.67

DCTH:

$0.01

PS Ratio

ATAI:

320.49

DCTH:

6.30

PB Ratio

ATAI:

8.10

DCTH:

3.45

Total Revenue (TTM)

ATAI:

$3.49M

DCTH:

$65.45M

Gross Profit (TTM)

ATAI:

$3.49M

DCTH:

$77.75M

EBITDA (TTM)

ATAI:

-$663.38M

DCTH:

$222.00K

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

ATAI vs. DCTH — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ATAI
ATAI Risk / Return Rank: 7171
Overall Rank
ATAI Sharpe Ratio Rank: 7272
Sharpe Ratio Rank
ATAI Sortino Ratio Rank: 7474
Sortino Ratio Rank
ATAI Omega Ratio Rank: 7171
Omega Ratio Rank
ATAI Calmar Ratio Rank: 7272
Calmar Ratio Rank
ATAI Martin Ratio Rank: 6666
Martin Ratio Rank

DCTH
DCTH Risk / Return Rank: 1616
Overall Rank
DCTH Sharpe Ratio Rank: 1212
Sharpe Ratio Rank
DCTH Sortino Ratio Rank: 1414
Sortino Ratio Rank
DCTH Omega Ratio Rank: 1515
Omega Ratio Rank
DCTH Calmar Ratio Rank: 1717
Calmar Ratio Rank
DCTH Martin Ratio Rank: 2424
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

ATAI vs. DCTH - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Atai Life Sciences N.V. (ATAI) and Delcath Systems, Inc. (DCTH). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


ATAIDCTHDifference
Sharpe ratioReturn per unit of total volatility

+1.73

Sortino ratioReturn per unit of downside risk

+2.78

Omega ratioGain probability vs. loss probability

1.24

0.90

+0.33

Calmar ratioReturn relative to maximum drawdown

1.72

-0.67

+2.38

Martin ratioReturn relative to average drawdown

2.79

-0.91

+3.70

ATAI vs. DCTH - Sharpe Ratio Comparison

The current ATAI Sharpe Ratio is 1.03, which is higher than the DCTH Sharpe Ratio of -0.70. The chart below compares the historical Sharpe Ratios of ATAI and DCTH, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


ATAIDCTHDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

1.03

-0.70

+1.73

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.00

Sharpe Ratio (All Time)

Calculated using the full available price history

-0.31

-0.44

+0.13

Drawdowns

ATAI vs. DCTH - Drawdown Comparison

The maximum ATAI drawdown since its inception was -94.77%, smaller than the maximum DCTH drawdown of -99.96%. Use the drawdown chart below to compare losses from any high point for ATAI and DCTH.


Loading charts...

Drawdown Indicators


ATAIDCTHDifference

Max Drawdown

Largest peak-to-trough decline

-94.77%

-99.96%

+5.19%

Max Drawdown (1Y)

Largest decline over 1 year

-48.06%

-51.45%

+3.39%

Max Drawdown (3Y)

Largest decline over 3 years

-59.23%

-68.97%

+9.74%

Max Drawdown (5Y)

Largest decline over 5 years

-82.21%

Current Drawdown

Current decline from peak

-77.38%

-99.82%

+22.44%

Average Drawdown

Average peak-to-trough decline

-79.77%

-96.46%

+16.69%

Ulcer Index

Depth and duration of drawdowns from previous peaks

29.52%

37.69%

-8.17%

Volatility

ATAI vs. DCTH - Volatility Comparison

Atai Life Sciences N.V. (ATAI) has a higher volatility of 15.38% compared to Delcath Systems, Inc. (DCTH) at 10.97%. This indicates that ATAI's price experiences larger fluctuations and is considered to be riskier than DCTH based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


ATAIDCTHDifference

Volatility (1M)

Calculated over the trailing 1-month period

15.38%

10.97%

+4.41%

Volatility (6M)

Calculated over the trailing 6-month period

49.13%

31.86%

+17.27%

Volatility (1Y)

Calculated over the trailing 1-year period

80.43%

49.10%

+31.33%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

83.66%

73.08%

+10.58%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

83.66%

110.12%

-26.46%

Dividends

ATAI vs. DCTH - Dividend Comparison

Neither ATAI nor DCTH has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

ATAI vs. DCTH - Financials Comparison

This section allows you to compare key financial metrics between Atai Life Sciences N.V. and Delcath Systems, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.005.00M10.00M15.00M20.00M25.00M20222023202420252026
954.00K
0
(ATAI) Total Revenue
(DCTH) Total Revenue
Values in USD except per share items

Frequently Asked Questions


ATAI and DCTH have a correlation of 0.30, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

ATAI has higher volatility (15.38%) compared to DCTH (10.97%). In terms of maximum drawdown, ATAI dropped -94.77% vs DCTH's -99.96%.

ATAI currently has the higher Sharpe Ratio (1.03 vs -0.70), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for ATAI and DCTH

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer